Lamotrigine Tablet
Product Images NDC 68382-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68382-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A8e89916 Ae5a 48af 9da1 8b9288d977fd 388 2

A8e89916 Ae5a 48af 9da1 8b9288d977fd 388 2
Lamotrigine 100 mg round white oral tablet with imprint 'ZC 79'. Manufactured by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 01

Fd77496d 56c7 476b 9231 0298034b1a17 01
Chemical structure of lamotrigine, showing a chlorinated phenyl ring and a triazine ring with amino substituents.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 02

Fd77496d 56c7 476b 9231 0298034b1a17 02
A line graph showing failure probability (%) over time in weeks, comparing Lamotrigine and placebo groups. Failure probability increases over weeks, with two distinct lines labeled for Lamotrigine and placebo. The graph includes censored data points marked along the lines.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 03

Fd77496d 56c7 476b 9231 0298034b1a17 03
A line graph comparing failure probability (%) over weeks for Lamotrigine and placebo. The x-axis represents time in weeks (0 to around 80), and the y-axis shows failure probability from 0 to 100%. Two curves are labeled 'Placebo' and 'Lamotrigine' with several censoring markers indicated. The graph shows how failure probability changes over time for each group.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 04

Fd77496d 56c7 476b 9231 0298034b1a17 04
Lamotrigine Tablets for Oral Suspension, USP 5 mg oral tablet label by Zydus Pharmaceuticals USA Inc. The label states the product is for prescription use only and contains 100 tablets. It includes cautions to verify the product dispensed and instructions to dispense the accompanying medication guide to patients. The label also provides storage and handling instructions and manufacturing and distribution details.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 05

Fd77496d 56c7 476b 9231 0298034b1a17 05
Lamotrigine Tablets for Oral Suspension, USP 25 mg label from Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-109-01, a caution to verify product dispensed, instructions to dispense the accompanying medication guide, and states the package contains 100 tablets for prescription use only. Additional storage, usage, and manufacturing details are included.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 06

Fd77496d 56c7 476b 9231 0298034b1a17 06
Lamotrigine Tablets, USP 25 mg oral tablets label by Zydus Pharmaceuticals USA Inc. The label states a package contains 100 tablets for prescription use only. It includes dosage strength, storage conditions, cautions, and manufacturer and distributor details. The label also includes a barcode, NDC 68382-006-01, and instructions to verify the product dispensed.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 07

Fd77496d 56c7 476b 9231 0298034b1a17 07
Packaging label for Lamotrigine Tablets, USP 50 mg by Zydus Pharmaceuticals USA Inc. The label includes dosage strength, NDC 68382-007-01, and a package size of 100 tablets. It advises pharmacists to dispense the medication guide and contains storage and safety instructions, manufacturer and distributor information.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 08

Fd77496d 56c7 476b 9231 0298034b1a17 08
Lamotrigine Tablets, USP 100 mg oral tablets packaging label from Zydus Pharmaceuticals USA Inc. The label shows 100 tablets in the package with Rx only designation and standard storage and safety instructions, including child resistance and dispensing guidelines.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 09

Fd77496d 56c7 476b 9231 0298034b1a17 09
Lamotrigine Tablets, USP 150 mg oral tablets packaging label by Zydus Pharmaceuticals USA Inc. The label shows 60 tablets per container, with a caution to verify the product dispensed and dispense the medication guide separately for each patient. It includes storage instructions and warnings about child resistance and seal integrity.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 10

Fd77496d 56c7 476b 9231 0298034b1a17 10
Lamotrigine Tablets, USP 200 mg oral tablets label from Zydus Pharmaceuticals USA Inc. The label indicates 60 tablets per bottle and includes storage instructions, dosage form, and cautions such as verifying product dispensed and keeping out of reach of children. The label also features a barcode and distributor details.*
FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 11

Fd77496d 56c7 476b 9231 0298034b1a17 11
Lamotrigine Tablets, USP 250 mg oral tablet label showing a quantity of 500 tablets. The label includes storage instructions, caution statements, and pharmacy dispensing information. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ. The label features the Zydus Pharmaceuticals logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.